Recently, five departments including the Guangdong Provincial Department of Science and Technology, Development and Reform Commission, Department of Industry and Information Technology, Health Commission, and Market Supervision Administration jointly issued the “Guangdong Provincial Action Plan for the Development of Biomedicine and Health Strategic Pillar Industry Clusters (2021-2025)”.
Among them, the content of the trial-first policy is highlighted:
(8) Guangdong-Hong Kong-Macao Greater Bay Area Pilot Policy Exploration Project. Strive for national permission for use by designated medical institutions operating in nine mainland cities in the Guangdong-Hong Kong-Macao Greater Bay Area. Strive for national permission to provide cutting-edge medical treatment services that have been approved by the competent authorities of developed countries or regions in designated medical institutions in the nine mainland cities in the Guangdong-Hong Kong-Macao Greater Bay Area. Encourage medical personnel from Hong Kong and Macao to come to Guangdong to carry out academic exchanges, and explore ways to promote qualified Hong Kong, Macao and foreign medical personnel to directly practice in the nine mainland cities in the Guangdong-Hong Kong-Macao Greater Bay Area. Promote the implementation of mutual recognition of registration standards and inspection standards for proprietary Chinese medicines in the Guangdong-Hong Kong-Macao Greater Bay Area, and build an integrated traditional Chinese medicine review mechanism. (The Provincial Health Commission and the Food and Drug Administration take the lead, and the Provincial Department of Science and Technology, the Hong Kong and Macao Affairs Office, and the Bureau of Traditional Chinese Medicine are responsible according to the division of responsibilities)
In addition, the document also proposed:
Support Shenzhen to build a global source of biopharmaceutical innovation and development, and develop high-performance medical devices, bioinformatics, and Cell and gene therapy and other fields.
Organization and implementation of precision medicine and stem cells, new drug creation, high-end medical equipment, key technical equipment of traditional Chinese medicine and other special projects to improve the level of pharmaceutical manufacturing, medical equipment and equipment manufacturing.
(Note: The nine mainland cities in the Guangdong-Hong Kong-Macao Greater Bay Area refer to Guangdong ProvinceGuangzhou, Shenzhen, Zhuhai, Foshan, Huizhou, Dongguan, Zhongshan, Jiangmen, ZhaoqingNine Pearl River Delta cities)